A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound

• मुख्य लेखकों: Iris C. Salaroglio (लेखक), Denitsa Stefanova (लेखक), Ricardo G. Teixeira (लेखक), Nuno F.B. Oliveira (लेखक), Amer Ahmed (लेखक), Fabio Fusi (लेखक), Virginia Tzankova (लेखक), Yordan Yordanov (लेखक), Miguel Machuqueiro (लेखक), Simona Saponara (लेखक), Andreia Valente (लेखक), Chiara Riganti (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2024-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The therapeutic approach to many solid tumors, including non-small cell lung cancer (NSCLC), is mainly based on the use of platinum-containing anticancer agents and is often characterized by acquired or intrinsic resistance to the drug. Therefore, the search for safer and more effective drugs is sti...